yh 439 has been researched along with lysine in 1 studies
| Studies (yh 439) | Trials (yh 439) | Recent Studies (post-2010) (yh 439) | Studies (lysine) | Trials (lysine) | Recent Studies (post-2010) (lysine) |
|---|---|---|---|---|---|
| 21 | 0 | 2 | 37,449 | 622 | 11,213 |
| Protein | Taxonomy | yh 439 (IC50) | lysine (IC50) |
|---|---|---|---|
| Cationic amino acid transporter 3 | Homo sapiens (human) | 158 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrasquillo, JA; Green, MV; Jeong, KS; Kim, IS; Kim, MK; Kobayashi, H; Paik, CH; Seidel, J; Soh, Y; Song, BJ | 1 |
1 other study(ies) available for yh 439 and lysine
| Article | Year |
|---|---|
Use of 99mTc-mercaptoacetyltriglycine (MAG3)-biocytin hepatobiliary scintigraphy to study the protective effect of a synthetic enzyme inhibitor on acute hepatotoxicity in mice.
Topics: Animals; Biliary Tract; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Liver; Liver Diseases; Lysine; Mice; Mice, Inbred BALB C; Necrosis; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Thiazoles | 1998 |